Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bifidobacterium Quadruple Live Tablets for Cirrhosis With Spontaneous Bacterial Peritonitis
NCT07686861Phase 4Not yet recruiting
- Sponsor
- Peking University First Hospital
- Start
- Jul 2026
- Primary completion
- Jul 2027
- Countries
- 1
01
Overview
A Phase 4 trial of bifidobacterium quadruple live tablets in Cirrhosis, spontaneous bacterial peritonitis (SBP), sponsored by Peking University First Hospital. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
bifidobacterium quadruple live tablets
03
Conditions
Cirrhosisspontaneous bacterial peritonitis (SBP)
Beyond the preview
Go deeper on NCT07686861.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07686861.